Is it possible to ask the Authorities for a voluntary Inspection of an API Manufacturer?
Recommendation

17/18 June 2026
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
We often receive question where people ask,
a) whether a GMP certificate based on an inspection of an EU Inspectorate can liberate the Marketing Authorisation holder from its responsibility to audit and
b) whether an API manufacturer can ask for an inspection to receive an EU GMP certificate
Already in a Q&A from 2006, it is said that inspection reports or GMP certificates issued by EEA "cannot fulfil the statutory obligations of the manufacturing authorisation holder or the requirements of section 5.25 of the GMP Guide, but the results of inspections, may be used together with other supporting information in a risk-based approach by the manufacturer in establishing priorities for its own audit programme of active substance suppliers".
Now, on the same Q&A website of the EMA, this question is answered again. Here it is clearly stated that "An inspection of the active substance manufacturer by an EEA authority does not liberate a MA holder from this responsibility".
Although there is a provision for the competent authority to carry out inspections of starting material manufacturers at the specific request of the manufacturer, there is "no guarantee that such a request will be fulfilled since competent authorities primarily use risk-based principles to plan starting material inspections". So there is no obligation for the respective inspectorate to do so.
Related GMP News
03.06.2026GMP Auditor Association Developments January through April 2026
20.05.2026CAPA and Root Cause Analysis - why FDA keeps calling them out
20.05.2026FDA Pilots One-Day Inspectional Assessments to Expand Oversight
06.05.2026FDA Warning Letter: CAPA not only needed for Deviations
28.04.2026FDA remains active in Europe - further Inspections despite MRAs


